Jasper Therapeutics

North America Legal Chronicle. February 27, 2024

Jasper Therapeutics’ $50 Million Common Stock Offering

By Sonia Carcano

Paul Hastings LLP advised Jasper Therapeutics, Inc., while DLA Piper advised the underwriters. Jasper Therapeutics, Inc. (Nasdaq: JSPR), a clinical-stage biotechnology company focused on developing novel...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

North America Legal Chronicle. February 1, 2023

Jasper Therapeutics’ $103.5 Million Public Offering

By Martina Bellini

Paul Hastings LLP advised Jasper Therapeutics on the deal. Jasper Therapeutics, Inc. (Nasdaq: JSPR) (“Jasper”), a biotechnology company focused on developing novel antibody therapies targeting c-Kit...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Insider’s $500 Million Series E Financing Round

Edison International’s $550 Million Notes Offering

Derq’s Investment Round

Reddy Ice’s Acquisition of Aguafría

‘Mercado Crédito XXVII’ Financial Trusts’ Issuance

Crescera Capital’s Acquisition of Segware

SKB’s Environmental Permit Application for Final Storage of Used Nuclear Fuel

B.P. Marsh & Partners Plc’s Sale Of Lilley Plummer Holdings Ltd.

PLAZZA’s CHF100 Million Bond Placement

Camusat Holding’s €81 Million Mezzanine Investment Round

Retail Holding’s Shareholders Reconfiguration

Ora Developers Egypt for Real Estate Investment’s Financing Round

Fourth Milling Company’s Initial Public Offering on Tadawul

A101 Yeni Magazacilik A.S.’ $200 Million Sustainability Loan

ADNH Catering’s US$235 Million Initial Public Offering

HomeLane’s Acquisition of DesignCafe

UBTech Robotics Corp Ltd’s HK$436 Million Shares Placement

Akasa Air’s Partnership with Rolls-Royce for Engine Leasing

Senior M&A Lawyer Deepa Vallabh Joins Bowmans in Johannesburg

Michael R. Guerrero Returns to Hinshaw’s Consumer Financial Services Group in California

James Barbaria Joins Hinshaw & Culbertson LLP as Chief Financial Officer

The Diarra Ruling On The Transfer Of Players Within The EU And The FIFA Regulation On The Status And Transfer Of Players

The Distinctive Character Of The ‘Vespa’ Is No Longer In Question

Cultural Heritage Sites With Restrictions On Intended Use: The Council of State Acknowledges That This Power Lies In the Hands Of The Ministry Of Culture

Senior M&A Lawyer Deepa Vallabh Joins Bowmans in Johannesburg

Michael R. Guerrero Returns to Hinshaw’s Consumer Financial Services Group in California

James Barbaria Joins Hinshaw & Culbertson LLP as Chief Financial Officer

Jasper Therapeutics’ $50 Million Common Stock Offering

Standard 1 Year Membership Required

Jasper Therapeutics’ $103.5 Million Public Offering

Standard 1 Year Membership Required